These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Protection against HIV - but only with good compliance!]. Oberhofer E MMW Fortschr Med; 2016 Jun; 158 Suppl 1():11. PubMed ID: 27259892 [No Abstract] [Full Text] [Related]
6. Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention. Murnane PM; Brown ER; Donnell D; Coley RY; Mugo N; Mujugira A; Celum C; Baeten JM; Am J Epidemiol; 2015 Nov; 182(10):848-56. PubMed ID: 26487343 [TBL] [Abstract][Full Text] [Related]
7. Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States. Rosenberg ES; Marcus JL Ann Epidemiol; 2018 Dec; 28(12):830-832. PubMed ID: 30224292 [No Abstract] [Full Text] [Related]
8. HOW DO I PAY FOR PrEP? Evans D Posit Aware; 2015; 27(5):18-9. PubMed ID: 26714339 [No Abstract] [Full Text] [Related]
9. MOVING FORWARD WITH PrEP. THE BASICS OF PrEP. Highleyman L Posit Aware; 2015; 27(5):2-3. PubMed ID: 26714333 [No Abstract] [Full Text] [Related]
10. Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection. Trang TP; Dong BJ; Kojima N; Klausner JD Expert Opin Drug Saf; 2016 Sep; 15(9):1287-94. PubMed ID: 27391203 [TBL] [Abstract][Full Text] [Related]
11. Truvada (emtricitabine/tenofovir) pre-exposure prophylaxis roll-out among South African university students: Lots of positives, but let us keep an eye on possible surprises. Montjane K; Dlamini S; Dandara C S Afr Med J; 2018 Feb; 108(2):79-81. PubMed ID: 29429434 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of HIV Pre-Exposure Prophylaxis as Part of Routine Care in Toronto, Canada. Rajchgot J; Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Cicci A; Bogoch II J Acquir Immune Defic Syndr; 2016 Jul; 72(3):e80-1. PubMed ID: 27035886 [No Abstract] [Full Text] [Related]
13. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns. Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774 [TBL] [Abstract][Full Text] [Related]
14. PrEP and the PrEPstars. Morgan J Lancet HIV; 2018 Nov; 5(11):e616. PubMed ID: 30104178 [No Abstract] [Full Text] [Related]
15. [HIV pre-exposure prophylaxis does not increase the rate of STI]. Blondel N Rev Med Suisse; 2016 Jan; 12(503):236. PubMed ID: 26939198 [No Abstract] [Full Text] [Related]
16. HIV moments and pre-exposure prophylaxis. Grant RM; Glidden DV Lancet; 2016 Apr; 387(10027):1507-1508. PubMed ID: 27115970 [No Abstract] [Full Text] [Related]
17. ACP Journal Club. Preexposure tenofovir-emtricitabine reduced HIV infection in men who have unprotected anal sex with men. Sacks HS Ann Intern Med; 2016 Jan; 164(2):JC3. PubMed ID: 26784493 [No Abstract] [Full Text] [Related]
18. Infection: PrEParation to be PROUD of. Stone L Nat Rev Urol; 2015 Nov; 12(11):596. PubMed ID: 26439506 [No Abstract] [Full Text] [Related]
19. HIV Antiretroviral Pre-Exposure Prophylaxis: Development Challenges and Pipeline Promise. Hendrix CW Clin Pharmacol Ther; 2018 Dec; 104(6):1082-1097. PubMed ID: 30199098 [TBL] [Abstract][Full Text] [Related]